Browse All

Current Filters

CLEAR FILTER x

TITLE

A Cross-Sectional Survey of Prevailing Opinions from Headache Specialists Regarding Status Migrainosus Management

Author:Robblee, Jennifer   Vann, Robert   Fitzpatrick, Christopher   Murphy, Michelle   Ray, Sutapa   Shrewsbury, Stephen   Aurora, Sheena   

Session Name:P11: Headache: Evaluating Paradigms for Optimal Outcomes  

Topic:Headache  

Program Number:P11.001  

Author Institution:Barrow Neurological Institute, Phoenix, AZ  Impel Pharmaceuticals, Seattle, WA  Impel Pharmaceuticals, Studio City, CA  

Assessment of the Potential for Drug–Drug Interactions Between INP104 and Gepants for Migraine Management Using a Model-based Approach

Author:Ray, Sutapa   Torphy, Bradley   Joshi, Shivang   Vann, Robert   Downing, Brett   Fonseca, Daniella   Shrewsbury, Stephen   Aurora, Sheena   

Session Name:P12: Headache: Clinical Trials and Real World Studies 2  

Topic:Headache  

Program Number:P12.008  

Author Institution:Impel Pharmaceuticals, Seattle, WA  Chicago Headache Center and Research Institute, Chicago, IL  Community Neuroscience Services, Westborough, MA  Impel Pharmaceuticals, Sturbridge, MA  Impel Pharmaceuticals, Fort Lauderdale, FL  

Safety and Efficacy of Concomitant Erenumab and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients

Author:Ahmed, Zubair   Vann, Robert   Fitzpatrick, Christopher   Ray, Sutapa   Shrewsbury, Stephen   Aurora, Sheena   

Session Name:P13: Headache: Therapeutics 1  

Topic:Headache  

Program Number:P13.002  

Author Institution:Cleveland Clinic, Cleveland, OH  Impel Pharmaceuticals, Seattle, WA  Impel Pharmaceuticals, Fallbrook, CA  

Safety of Concomitant Triptan and INP104 Use From the Phase 3 STOP 301 Study in Migraine Patients

Author:Feoktistov, Alexander   Vann, Robert   Gutierrez, Judie   Ray, Sutapa   Shrewsbury, Stephen   Aurora, Sheena   

Session Name:P14: Headache: Therapeutics 2  

Topic:Headache  

Program Number:P14.011  

Author Institution:Synergy Integrative Headache Center, Northfield, IL  Impel Pharmaceuticals, Seattle, WA